Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa

Clinical Neuropharmacology

Volumn 23, Issue 6, 2000, Pages 324-330

  Rabey, J M ^a,b   Sagi, I ^a,b   Huberman, M ^a,b   Melamed, E ^a,b   Korczyn, A ^a,b   Giladi, N ^a,b   Inzelberg, R ^a,b   Djaldetti, R ^a,b   Klein, C ^a,b   Berecz, G ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

MAO B inhibiting rasagiline; Motor fluctuations; Parkinson's disease

Indexed keywords

LEVODOPA; MONOAMINE OXIDASE INHIBITOR; RASAGILINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE;

ADULT; AGED; ANTIPARKINSON AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDANS; LEVODOPA; MALE; MIDDLE AGED; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PARKINSON DISEASE;

EID: 0034519674     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200011000-00005     Document Type: Article

References (15)

1. Introduction
2. On-off effects in subjects with Parkinson's disease on chronic levodopa therapy
3. Tyramine antagonist properties of AGN 1130. An irreversible inhibitor of monoamine oxidase type B
4. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-dopa in hemiparkinsonian rats
5. R (+) N-propargyl-1-aminoindan (rasagiline) and derivatives: Highly selective and potent inhibitors of monoamine-oxidase B
6. Effects of N-propargyl-1-® aminoindan (rasagiline) in models of motor and cognition disorders
7. Increased survival of dopaminergic neurons by rasagiline
8. Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation
9. Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat
10. TVP-1012, an irreversible MAO-B inhibitor protects against MPTP-neurotoxicity in the monkey - Comparison with L-deprenyl
11. Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat
12. Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse
13. Unified Parkinson's Disease Rating Scale
14. Clinical Global Assessment Scale (CGI)